Molecular modeling software plus applications to help individuals with disabilities equals Simulations Plus. The company is a leading provider of applications used by pharmaceutical researchers to model absorption rates for orally dosed drug compounds. Its Words+ subsidiary provides augmentative communication software and input devices that help people with disabilities use computers. Simulations Plus also provides educational software targeted to high school and college students through its FutureLab unit. Pharmaceutical giants GlaxoSmithKline and Roche are among its clients. CEO Walter Woltosz and his wife, Virginia (a director), together own about 40% of the company.